In individuals who started antiretroviral therapy during acute HIV infection, the proliferative capacity of HIV-specific CD8+ T-cells at 24 weeks of therapy predicted the subsequent reduction in the ...
News organizations may use or redistribute this image, with proper attribution, as part of news coverage of this paper only.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results